FDA Inspection 1085474 — Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc — FEI 3012853807

The FDA completed an inspection of Intra-Cellular Therapies Inc on March 22, 2019 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol
748221 CFR 312.50General responsibilities of sponsors